Having trouble viewing this e-mail? CLICK HERE

Pharm Tech
September 2017
Volume 29, No. 8
VIEW ONLINE ARCHIVE SUBSCRIBE FORWARD Twitter LinkedIn
advertisement

| COVER STORY |

Breaking Through Red Tape to Modernize Manufacturing

Agnes Shanley

Systems that discourage continuous improvement threaten pharma innovation, quality, and supply. Can the industry break through this deadlock?
/ read more /


Lawrence Yu on Encouraging Innovation at the United States Food and Drug Administration

Agnes Shanley

Lawrence Yu, Deputy Director, Office of Pharmaceutical Quality at FDA's Center for Drug Evaluation and Research (CDER), shares insights on the agency's efforts to support modern manufacturing.
/ read more /


Inside the United States Food and Drug Administration's Emerging Technologies Team

Agnes Shanley

FDA's Emerging Technologies Team (ETT) team chair Sau Lee describes the reasons for the team and its structure.
/ read more /

advertisement
PharmTech Europe September Issue
Download on the app store Read the issue online Subscribe or renew your Pharm Tech subscription

| API SYNTHESIS & MANUFACTURING |

Optimizing Cell-Culture Media

Cynthia A. Challener

Media manufacturers are focused on reducing risk, improving quality and consistency, and managing costs.
/ read more /


| FORMULATION |

Targeting Drug Delivery with ADCs

Adeline Siew

Safe and effective drug targeting with ADCs requires careful selection of drug, antibody, and linker.
/ read more /


| MANUFACTURING |

Using QbD in Topical Drug Manufacturing

Jennifer Markarian

Characterization of the product and process is key for process development and scale-up of topical drug manufacturing using a QbD approach.
/ read more /


| ANALYTICS |

A Continuous Improvement Metric for Pharmaceutical Manufacturing

Jordan Collins, Naheed Sayeed-Desta, Ajay Pazhayattil, Chetan Doshi

Statistical methods and novel indices can be used to monitor and benchmark variability, and guide continuous improvement programs in late-stage drug development.
/ read more /


| QUALITY |

Avoiding Investigational Failure/Discrepancy-Related Form 483 Observations

Walt Murray, James Jardine

Investigational failures and discrepancies can be avoided through the proper execution and documentation of investigations.
/ read more /


| PEER-REVIEWED RESEARCH |

Establishing Acceptance Limits for Uniformity of Dosage Units: Part Two

Pramote Cholayudth

The author describes how to establish acceptance limits for acceptance value (AV) data for process validation batches, typical characteristics of AV distributions, and how to derive relevant constants for AV control charts in annual product review and continued process verification reports.
/ read more /


| EU REGULATORY WATCH |

EMA Increases Support for SMEs

Sean Milmo

EMA recognizes the need to provide more assistance and guidance to SMEs developing new medicines and applying for marketing authorizations.
/ read more /


| ASK THE EXPERT |

A Look at Batch Record Review

Susan J. Schniepp

The review of batch records creates a story of the materials, manufacturing, and packaging involved in the production of bio/pharmaceuticals, according to Susan Schniepp, distinguished fellow at Regulatory Compliance Associates.
/ read more /


| EVENTS |

CPhI Korea

Seoul, Korea
22–24 August 2017

Workshop on Continuous Pharmaceutical Manufacturing: From Powder to the Coated Tablet

Ennigerloh, Germany
19–21 September 2017

more events
Contribute an article | contact the editors | contact sales | subscribe | advertise